GEODE CAPITAL MANAGEMENT, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 72 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$980,251
+30.3%
510,431
-2.3%
0.00%
Q2 2023$752,091
-31.3%
522,286
+0.1%
0.00%
Q1 2023$1,095,523
+188783.3%
521,678
+1.5%
0.00%
Q4 2022$580
-99.9%
513,815
-0.0%
0.00%
Q3 2022$837,000
+25.1%
513,902
+0.5%
0.00%
Q2 2022$669,000
-25.5%
511,139
-8.4%
0.00%
Q1 2022$898,000
-22.5%
558,240
-0.3%
0.00%
Q4 2021$1,158,000
-44.8%
559,728
+3.5%
0.00%
Q3 2021$2,098,000
+60.4%
540,866
+32.2%
0.00%
Q2 2021$1,308,000
-6.6%
409,013
-36.7%
0.00%
Q1 2021$1,401,000
-2.6%
645,867
+0.6%
0.00%
Q4 2020$1,438,000
-9.4%
642,104
+8.0%
0.00%
Q3 2020$1,587,000
-12.6%
594,621
+0.2%
0.00%
Q2 2020$1,816,000
+65.1%
593,700
+5.8%
0.00%
Q1 2020$1,100,000
-64.7%
561,368
-48.5%
0.00%
Q4 2019$3,114,000
+80.4%
1,089,146
+131.5%
0.00%
Q3 2019$1,726,000
-11.3%
470,556
+0.3%
0.00%
Q2 2019$1,946,000
+36.2%
469,063
+67.7%
0.00%
Q1 2019$1,429,000
-8.3%
279,748
-38.4%
0.00%
Q4 2018$1,558,000
+22.5%
454,350
+114.6%
0.00%
Q3 2018$1,272,000
-1.2%
211,765
+4.5%
0.00%
Q2 2018$1,288,000
+39.1%
202,563
+3.7%
0.00%
Q1 2018$926,000
+42.0%
195,4110.0%0.00%
Q4 2017$652,000
+57.5%
195,4110.0%0.00%
Q3 2017$414,000
-13.8%
195,4110.0%0.00%
Q2 2017$480,000
+92.0%
195,411
+79.3%
0.00%
Q1 2017$250,000
+135.8%
109,011
+0.7%
0.00%
Q4 2016$106,000
-12.4%
108,237
+0.5%
0.00%
Q3 2016$121,000
-23.4%
107,721
+0.1%
0.00%
Q2 2016$158,000
+3.3%
107,5920.0%0.00%
Q1 2016$153,000
-13.1%
107,592
-0.1%
0.00%
Q4 2015$176,000
-24.8%
107,721
+7.6%
0.00%
Q3 2015$234,000
-14.0%
100,109
+0.3%
0.00%
Q2 2015$272,000
-29.0%
99,851
-12.9%
0.00%
Q1 2015$383,000
+0.3%
114,599
+4.0%
0.00%
Q4 2014$382,000
-30.9%
110,207
+0.1%
0.00%
Q3 2014$553,000
-63.6%
110,045
+0.1%
0.00%
-100.0%
Q2 2014$1,518,000
+33.9%
109,937
+48.4%
0.00%0.0%
Q1 2014$1,134,000
+92.9%
74,072
+1.7%
0.00%
Q4 2013$588,000
+32.7%
72,869
+64.2%
0.00%
Q3 2013$443,000
+214.2%
44,385
+34.0%
0.00%
Q2 2013$141,00033,1280.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$565,0000.18%
D.A. DAVIDSON & CO. 851,101$2,604,0000.05%
Iron Gate Global Advisors LLC 17,090$52,0000.02%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$37,0000.02%
IHT Wealth Management, LLC 28,155$86,0000.01%
OSAIC HOLDINGS, INC. 1,012,430$3,098,0000.01%
Ameritas Investment Company, LLC 10,782$33,0000.01%
Vivaldi Capital Management LP 15,439$40,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$48,0000.01%
Geneos Wealth Management Inc. 37,017$108,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders